Bildkälla: Stockfoto

Alzinova: Exciting external news - Redeye

Redeye leaves a short comment on the exclusive option and license agreement between AC Immune and Takeda for the Alzheimer’s disease vaccine candidate ACI-24.060.

Redeye leaves a short comment on the exclusive option and license agreement between AC Immune and Takeda for the Alzheimer’s disease vaccine candidate ACI-24.060.
Börsvärldens nyhetsbrev
ANNONSER